Stock GALT GALECTIN THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Galectin Therapeutics Inc.

Equities

GALT

US3632252025

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
3.45 USD -1.43% Intraday chart for Galectin Therapeutics Inc. +2.37% +107.83%
03-29 Galectin Therapeutics Inc. Appoints Benjamin S. Carson as Member of the Board of Directors CI
03-29 Galectin Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on Galectin Therapeutics Inc.

Price target over the last 5 years

History of analyst recommendation changes

5aa4.Qz8i-x49bzSUU-je_xNPRkyo9m5vst0vRzXXLWWPY-g.EApYklRXW07zIaGbjUwAJWHFgT4ci5tACWaWdDC_J50RT3XIUXFbUcJmgw~586d54e6f253b1d5e8d0e519d955672e

Analyst Recommendations on Galectin Therapeutics Inc.

HC Wainwright Adjusts Price Target on Galectin Therapeutics to $11 From $14, Reiterates Buy Rating MT
GALECTIN THERAPEUTICS : HC Wainwright Adjusts Price Target on Galectin Therapeutics to $14 From $12, Maintains Buy Rating MT
Galectin Therapeutics to Present at Berenberg NASH Day in New York GL
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.45 USD
Average target price
11 USD
Spread / Average Target
+218.84%
High Price Target
11 USD
Spread / Highest target
+218.84%
Low Price Target
11 USD
Spread / Lowest Target
+218.84%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Galectin Therapeutics Inc.

HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. GALT Stock
  4. Consensus Galectin Therapeutics Inc.